Kupffer cell activation and portal hypertension

Gut

Volumn 60, Issue 10, 2011, Pages 1307-1308

  Steib, Christian J ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD163 ANTIGEN; HAPTOGLOBIN; HEME OXYGENASE 1; HEMOGLOBIN;

CELL ACTIVATION; DENDRITIC CELL; DISEASE MODEL; ENDOCYTOSIS; ENDOTHELIUM CELL; ENDOTOXEMIA; HUMAN; INNATE IMMUNITY; KUPFFER CELL; LIVER CIRRHOSIS; LIVER FAILURE; MACROPHAGE; NATURAL KILLER CELL; NONHUMAN; NOTE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHAGOCYTOSIS; PORTAL HYPERTENSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STELLATE CELL; UPREGULATION;

FEMALE; HUMANS; HYPERTENSION, PORTAL; KUPFFER CELLS; LIVER CIRRHOSIS; MACROPHAGE ACTIVATION; MALE; PORTAL PRESSURE; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; RECOVERY OF FUNCTION;

EID: 80052566958     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2011.242560     Document Type: Note

References (19)

1. Marra F., Aleffi S., Galastri S., et al. Mononuclear cells in liver fibrosis. Semin Immunopathol 2009;31:345-358
2. Steib C.J., Gerbes A.L. Signaling pathways in liver diseases Kupffer cells. In: Dufour J-F, Clavien P-A, eds. Signaling Pathways in Liver Diseases. Heidelberg: Springer Verlag, 2010:69-78.
3. Bilzer M., Roggel F., Gerbes A.L. Role of Kupffer cells in host defense and liver disease. Liver Int 2006;26:1175-1186 (Pubitemid 44741204)
4. Kristiansen M., Graversen J.H., Jacobsen C., et al. Identification of the haemoglobin scavenger receptor. Nature 2001;409:198-201. (Pubitemid 32144285)
5. Willekens F.L., Werre J.M., Kruijt J.K., et al. Liver Kupffer cells rapidly remove red blood cell-derived vesicles from the circulation by scavenger receptors. Blood 2005;105:2141-2145 (Pubitemid 40731805)
6. Holland-Fischer P., Grønbæk H., Sandahl T.D., et al. Kupffer cells are activated in cirrhotic portal hypertension and not normalised by TIPS. Gut 2011;60:1389-1393
7. Wilmer A., Nolchen B., Tilg H., et al. Serum neopterin concentrations in chronic liver disease. Gut 1995;37:108-112
8. Schauer R.J., Bilzer M., Kalmuk S., et al. Microcirculatory failure after rat liver transplantation is related to Kupffer cell-derived oxidant stress but not involved in early graft dysfunction. Transplantation 2001;72:1692-1699 (Pubitemid 33096749)
9. Xu H., Korneszczuk K., Karaa A., et al. Thromboxane A2 from Kupffer cells contributes to the hyperresponsiveness of hepatic portal circulation to endothelin-1 in endotoxemic rats. Am J Physiol Gastrointest Liver Physiol 2005;288:G277-G283 (Pubitemid 40129579)
10. Steib C.J., Bilzer M, op den Winkel M, et al. Treatment with the leukotriene inhibitor montelukast for 10 days attenuates portal hypertension in rat liver cirrhosis. Hepatology 2010;51:2086-2096
11. Zhou Q., Hennenberg M., Trebicka J., et al. Intrahepatic upregulation of RhoA and Rho-kinase signalling contributes to increased hepatic vascular resistance in rats with secondary biliary cirrhosis. Gut 2006;55:1296-1305 (Pubitemid 44277362)
12. Steib C.J., Hennenberg M., Beitinger F., et al. Amiloride reduces portal hypertension in rat liver cirrhosis. Gut 2010;59:827-836
13. Bautista A.P., Spolarics Z., Jaeschke H., et al. Antineutrophil monoclonal antibody (1F12) alters superoxide anion release by neutrophils and Kupffer cells. J Leukoc Biol 1994;55:328-335 (Pubitemid 24097238)
14. Hiraoka A., Horiike N., Akbar S.M., et al. Soluble CD163 in patients with liver diseases: Very high levels of soluble CD163 in patients with fulminant hepatic failure. J Gastroenterol 2005;40:52-56 (Pubitemid 40796332)
15. Moller H.J., Gronbaek H., Schiodt F.V., et al. Soluble CD163 from activated macrophages predicts mortality in acute liver failure. J Hepatol 2007;47:671-676 (Pubitemid 47503425)
16. Etzerodt A., Maniecki M.B., Moller K., et al. Tumor necrosis factor alpha-converting enzyme (TACE/ADAM17) mediates ectodomain shedding of the scavenger receptor CD163. J Leukoc Biol 2010;88:1201-1205
17. Moller H.J., Peterslund N.A., Graversen J.H., et al. Identification of the hemoglobin scavenger receptor/CD163 as a natural soluble protein in plasma. Blood 2002;99:378-380 (Pubitemid 34533008)
18. Davis B.H., Zarev P.V. Human monocyte CD163 expression inversely correlates with soluble CD163 plasma levels. Cytometry B Clin Cytom 2005;63:16-22. (Pubitemid 40096840)
19. Zimmermann H.W., Seidler S., Nattermann J., et al. Functional contribution of elevated circulating and hepatic non-classical CD14CD16 monocytes to inflammation and human liver fibrosis. PLoS One 2010;5:e11049.